Can I get you opinion on the following:
- The fact that the 'launch' conveniently occurred on the last day of the FY? Do you think there may have been a KPI tied to 'Launching' in the 21/22 FY? It just seems very convenient that the announcement occurred on THAT day when the actual launch did not occur until a few days later....
- The FACT that the product is now NOT a COVID preventing device in the UK?
- What impacts this rebranding in the UK will have on device registration and approvals in other regions? i.e. Is VIRALEZE going to be able to be advertised as a COVID preventing device anywhere now? There was a lot of talk early in the approvals process around the fact that governing bodies around the world tend to follow each others lead.
I really want to hear your opinion as I know it will take a positive spin on all of the above. Personally, I can't find a way to spin this into a positive.
- Forums
- ASX - By Stock
- SPL
- Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK, page-97
-
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.7¢ | $38.11K | 389.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20455 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 38876 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20455 | 0.097 |
1 | 100000 | 0.096 |
2 | 60526 | 0.095 |
1 | 10000 | 0.094 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 38876 | 3 |
0.105 | 199768 | 2 |
0.110 | 226808 | 10 |
0.115 | 85453 | 2 |
0.120 | 79405 | 9 |
Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |